A detailed history of Bahl & Gaynor Inc transactions in Alcon Inc stock. As of the latest transaction made, Bahl & Gaynor Inc holds 8,029 shares of ALC stock, worth $686,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,029
Previous 8,029 -0.0%
Holding current value
$686,800
Previous $715,000 12.31%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$77.58 - $92.26 $31,187 - $37,088
-402 Reduced 4.77%
8,029 $715,000
Q1 2024

May 10, 2024

SELL
$74.84 - $88.15 $19,907 - $23,447
-266 Reduced 3.06%
8,431 $702,000
Q4 2023

Feb 02, 2024

SELL
$69.57 - $78.12 $4,869 - $5,468
-70 Reduced 0.8%
8,697 $679,000
Q3 2023

Nov 03, 2023

BUY
$76.74 - $85.2 $5,371 - $5,964
70 Added 0.8%
8,767 $675,000
Q2 2023

Aug 14, 2023

SELL
$69.16 - $82.11 $26,557 - $31,530
-384 Reduced 4.23%
8,697 $714,000
Q1 2023

May 03, 2023

SELL
$64.46 - $77.23 $21,594 - $25,872
-335 Reduced 3.56%
9,081 $640,000
Q4 2022

Feb 10, 2023

SELL
$56.51 - $71.71 $9,324 - $11,832
-165 Reduced 1.72%
9,416 $645,000
Q3 2022

Nov 14, 2022

SELL
$56.96 - $78.09 $5,126 - $7,028
-90 Reduced 0.93%
9,581 $557,000
Q2 2022

Aug 08, 2022

SELL
$64.25 - $81.25 $46,260 - $58,500
-720 Reduced 6.93%
9,671 $676,000
Q1 2022

May 12, 2022

SELL
$71.65 - $87.13 $153,760 - $186,980
-2,146 Reduced 17.12%
10,391 $824,000
Q4 2021

Feb 10, 2022

SELL
$77.91 - $88.5 $10,751 - $12,213
-138 Reduced 1.09%
12,537 $1.09 Million
Q3 2021

Nov 15, 2021

SELL
$68.18 - $87.25 $78,611 - $100,599
-1,153 Reduced 8.34%
12,675 $1.02 Million
Q2 2021

Aug 06, 2021

SELL
$66.27 - $76.21 $39,828 - $45,802
-601 Reduced 4.17%
13,828 $972,000
Q1 2021

May 11, 2021

SELL
$65.32 - $76.01 $39,845 - $46,366
-610 Reduced 4.06%
14,429 $1.01 Million
Q4 2020

Feb 02, 2021

SELL
$56.82 - $66.57 $94,491 - $110,705
-1,663 Reduced 9.96%
15,039 $992,000
Q3 2020

Nov 12, 2020

SELL
$55.23 - $62.39 $35,844 - $40,491
-649 Reduced 3.74%
16,702 $951,000
Q2 2020

Aug 13, 2020

SELL
$49.45 - $64.16 $80,356 - $104,260
-1,625 Reduced 8.56%
17,351 $995,000
Q1 2020

May 26, 2020

BUY
$39.86 - $63.46 $756,383 - $1.2 Million
18,976 New
18,976 $964,000
Q1 2020

May 15, 2020

SELL
$39.86 - $63.46 $825,620 - $1.31 Million
-20,713 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$55.04 - $59.27 $69,350 - $74,680
-1,260 Reduced 5.73%
20,713 $1.17 Million
Q3 2019

Nov 14, 2019

SELL
$58.2 - $62.42 $519,318 - $556,973
-8,923 Reduced 28.88%
21,973 $1.28 Million
Q2 2019

Aug 12, 2019

BUY
$54.43 - $63.33 $1.68 Million - $1.96 Million
30,896 New
30,896 $1.92 Million

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $41.9B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Bahl & Gaynor Inc Portfolio

Follow Bahl & Gaynor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bahl & Gaynor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bahl & Gaynor Inc with notifications on news.